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Abstract
Background: There appear to be geographical differences in decisions to perform mastectomy or
breast conserving surgery for early-stage breast cancer. This study was carried out to evaluate
general surgeons' preferences in breast cancer surgery and to assess the factors predicting cancer
practice in Iran.
Methods: A structured questionnaire was mailed to 235 general surgeons chosen from the
address list of the Iranian Medical Council. The questionnaire elicited information about the general
surgeons' characteristics and about their work experience, posts they have held, number of breast
cancer operations performed per year, preferences for mastectomy or breast conserving surgery,
and the reasons for these preferences.
Results: In all, 83 surgeons returned the completed questionnaire. The results indicated that only
19% of the surgeons routinely performed breast conserving surgery (BCS) and this was significantly
associated with their breast cancer case load (P < 0.01). There were no associations between BCS
practice and the other variables studied. The most frequent reasons for not performing BCS were
uncertainty about conservative therapy results (46%), uncertainty about the quality of available
radiotherapy services (32%), and the probability of patients' non-compliance in radiotherapy (32%).
Conclusion: The findings indicate that Iranian surgeons do not routinely perform BCS as the first
and the best treatment modality. Further research is recommended to evaluate patients' outcomes
after BCS treatment in Iran, with regard to available radiotherapy facilities and cultural factors
(patients' compliance).
Background
Many randomized clinical trials have demonstrated that
patient survival rates are similar after treatment by mastec-
tomy or by conservative surgery and radiotherapy [1-4].
However, the National Institute of Health Consensus
Conference concluded that for most women with early-
stage breast cancers (stages I and II), breast conservation
surgery (BCS) is an appropriate method of treatment [5].
Despite these findings, mastectomy remains the most
prevalent surgical treatment for early-stage breast cancer
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in many parts of the world. In Iran, BCS is an uncommon
modality for this condition. For example, in one study in
Isfahan University of Medical Sciences, 386 breast cancer
patients were reviewed and mastectomy was found to be
the most prevalent surgical treatment [6]. Similarly, in
another study in Tehran University of Medical Sciences,
348 breast cancer patients of whom 50% had stage I or
stage II breast cancer were evaluated, and it was found that
only 22 patients underwent BCS [7].
It is argued that one factor influencing choice of treatment
in breast cancer patients is the attitude of the operating
surgeon. There is evidence that most women follow sur-
geons' recommendations, their primary source of infor-
mation about treatment options. Studies have shown that
surgeons recommended a specific treatment option in
69% of cases; in 89% of these cases they offered mastec-
tomy and in 11% BCS. The rates of compliance with these
recommendations were reported to be 93% and 89%
respectively [8].
The present study was designed to evaluate the preferences
of surgeons in Iran regarding breast cancer treatment and
the factors influencing the type of treatment
recommended.
Methods
A descriptive study was conducted to investigate cancer
practice among general surgeons in Iran. A specially
designed questionnaire was mailed to a sample of 235
general surgeons, selected randomly from the Iranian
Medical Council's address list for general surgeons and
including a few surgical oncologists. All general surgeons
(n = 1977, 1831 male and 146 female) belong to the
Council. It is worth noting that in Iran, gynecologists and
plastic surgeons do not perform breast cancer surgery. The
sample size was determined by expectations of the rate of
BCS treatment by the general surgeons: it was estimated
that at best 15% and at worst 5% of the surgeons might
perform BCS. Based on this assumption, a sample of 81
surgeons would give results with a 99% confidence level.
To achieve this sample size it was decided to mail the
questionnaire to 235 general surgeons, nearly three times
more than needed. The questionnaire addressed the sur-
geons' characteristics including age, gender, work experi-
ence, posts held (teaching hospitals or private and public
institutions), and number of breast cancer patients treated
per year. In addition, respondents were asked whether
they routinely performed BCS, and if the answer was "no"
the reasons were solicited. Data were analyzed in a
descriptive fashion, reporting numbers and percentages
and using the chi-square test (Fisher's exact test) where
necessary.
Results
In all, 83 completed questionnaires were returned, giving
a response rate of 33%. The characteristics of the study
sample are shown in Table 1. The mean age of the
respondents was 55.2 years (SD = 12.3; range 32 to 80).
Most surgeons were male (n = 75, 90%), had more than
10 years work experience (76%), and were working at
public or private centers (75%). For 80% of the surgeons
surveyed, the average number of breast cancer patients
treated per year was less than 20; 20% reported that their
annual case-load was more than 20.
Only 19% of the surgeons said that they performed BCS
routinely. Table 2 shows the reasons given for avoiding
BCS. The most frequent reason was the surgeons' uncer-
tainty about the results of breast conserving surgery
(46.3%). The other most frequently-stated barriers to per-
forming BCS were uncertainty about radiotherapy services
and patients' non-compliance in radiotherapy (32.8%).
Of the factors studied, only breast cancer case-load had a
statistically significant association with performance of
BCS (P = 0.007). The results are shown in Table 3.
Table 1: The characteristics of the study sample
Number %
Age (years)
<40 14 17
40–59 37 45
≥60 32 38
Mean (SD) 55.2 (12.3)
Gender
Female 8 10
Male 75 90
City of practice
Tehran (the capital) 20 24
Other cities 63 76
Work experience (years)
≤10 20 24
>10 63 76
Mean (SD) 23.2 (12.7)
Occupation status
Working at a teaching hospital. 21 25
Working at a public/private hospital 62 75
Breast cancer case load (patient/per 
year, n = 70)
≤20 56 80
>20 14 20
Preferred type of surgery for breast 
cancer
Mastectomy 67 81
Breast conserving surgery 16 19BMC Cancer 2005, 5:35 http://www.biomedcentral.com/1471-2407/5/35
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Discussion
Breast-conserving surgery is a treatment modality for
early-stage breast cancer that causes less physical disfigure-
ment and psychological trauma to the patient. Many pro-
spective randomized trials have demonstrated that overall
and disease-free survival rates for early-stage breast cancer
are equivalent after mastectomy or BCS with postopera-
tive radiotherapy [2-4], [8,9]. There appear to be geo-
graphical differences in the surgical treatment of early-
stage breast cancer. Evidence suggests that physician rec-
ommendation exerts the most significant influence on
surgical treatment selection for the majority of women
[10].
In this study only 19% of surgeons used BCS in their prac-
tice while the remaining 81% performed mastectomy.
This concurs with two other studies, performed in Tehran
and Isfahan University of Medical Sciences, showing that
mastectomy was the most prevalent surgical treatment for
breast cancer patients [6,7]. However, it is arguable that
BCS rates would rise in Iran if general surgeons, for exam-
ple, could benefit from continuing medical education,
attend scientific meetings, and have access to modern text-
books and current journals. Discussion of these topics lies
beyond the scope of this study. Briefly, it should be noted
that there is a National Society of Surgeons in Iran. In
addition to other scientific meetings that address oncol-
ogy issues, members of this society have their own annual
and occasional scientific meetings, and usually receive
printed educational materials including issues on current
technology. At present all surgeons and radiation thera-
pists in teaching hospitals and many working in the pri-
vate sector are Board-certified. Some modern radiation
therapy facilities in Iran are very similar to existing facili-
ties in developed countries. Furthermore, we suspect that
predicting patient non-compliance with radiation therapy
might be subjective impressions on the part of the sur-
geons, since there is no evidence or published data to indi-
cate that patient compliance with radiation therapy is low.
The findings indicated that gender had no effect on the
performance of BCS. This may be due to the small number
Table 3: Association between breast cancer practice and the respondents' characteristics
Breast conservation No. (%) Mastectomy No. (%) P value
Gender 0.35
Male 14 (82) 61 (92)
Female 3 (18) 5 (8)
Age (years) 0.60
<40 4 (24) 10 (15)
40–59 6 (35) 31 (47)
≥60 7 (41) 25 (38)
Work experience 1.0
≤10 4 (24) 16 (24)
>10 13 (76) 50 (76)
Working at a teaching hospital 0.12
Yes 7 (41) 14 (21)
No 10 (59) 52 (79)
Breast cancer case load of the surgeon (n = 70) 0.007
≤20 8 (53) 48 (87)
>20 7 (47) 7 (13)
Table 2: Reasons stated by the surgeons for avoiding conservative therapy*
Number % of the study sample
Uncertainty about results of conservative therapy 32 46.3
Uncertainty about radiotherapy services 22 32.8
Probability of patient incompliance 22 32.8
Unavailability of radiotherapy services 17 25.4
Higher cost of conservative therapy 12 17.9
Lack of enough experience for performing BCS 10 14.9
* The total exceeds the sample size since each respondent could state several reasons.BMC Cancer 2005, 5:35 http://www.biomedcentral.com/1471-2407/5/35
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of female surgeons in this study. Similarly, in a study com-
paring rates of BCS between male and female surgeons, no
statistically significant difference was found between the
two groups [11]. However, it is interesting that in our
study, 14 out of the 75 male surgeons (19%) indicated
that they routinely perform BCS, while 3 out of the 8
female surgeons (38%) stated that they performed BCS.
We found that the surgeons' age and work experience was
not significantly associated with performing BCS; other
studies have shown that younger surgeons are more likely
to perform BCS. In one retrospective study that reviewed
the medical records of 952 patients, it was found that sur-
geons who graduated after 1960 performed BCS more fre-
quently than those who graduated before 1960 [12].
Another study showed that surgeons who graduated after
1980 performed BCS at a significantly higher rate than
those who graduated before 1961 [13]. However, the
mean age of our study sample was 55.2 (SD = 12.3) years
and the mean duration of work experience was 23.2 years
(SD = 12.7). In other words, most of our participants were
old; only 17% were relatively young. This might explain
why most surgeons in this study stated that they per-
formed mastectomy. This is also consistent with the fact
that mastectomy is the most prevalent surgical therapy for
breast cancer in our teaching hospitals [6,7]. However, the
findings from the present study indicate that there is a
trend towards more BCS at teaching hospitals, and it is
very likely that a bigger sample would show a significant
difference between teaching hospitals and private
institutes.
There was a statistically significant association between
the experience of the surgeons (measured by the number
of beast cancer patients treated per year) and performance
of BCS. Surgeons treating more than 20 breast cancer
patients per year had a statistically significant higher BCS
rate (P = 0.007). Few studies have reported a correlation
between the surgeons' experience and their breast conser-
vation surgery rates. A population-based study found that
patients treated by surgeons with higher breast cancer
case-loads were more likely to receive breast conservation
therapy [14]. A survey of surgeons carried out in 1986
showed no evidence of a relationship between the
number of breast surgery operations performed and the
rate of conservative surgery; but in a repeat survey in 1990,
when the overall conservative surgery rate had risen to
42%, a significant association was found for surgeons
treating 20 or more patients per year [13].
In this study, the most common reasons given for avoid-
ing BCS were uncertainty about the results of breast con-
servation therapy (46.3%), uncertainty about the quality
of available radiotherapy services (32%), and probability
of patient non-compliance (32%). Other reasons noted
by the surgeons were the higher cost of breast conserving
therapy (17.9%), non-availability of radiotherapy facili-
ties (25.4%), and insufficiency of experience with the BCS
technique (14.9%). A few studies have reported surgeons'
reasons for avoiding BCS. In one study, the majority of
surgeons believed that long-term disease-free survival was
equal for mastectomy and BCS, and the preference for
mastectomy was mostly due to the inconvenience of radi-
otherapy [15].
Conclusion
In conclusion, considering the study limitations (e.g. the
sample size was small, the surgeons were predominantly
old and only eight of them were female), the findings sug-
gest that the overall performance of BCS in Iran is low. In
order to increase the rate of conservation therapy there is
need to study the outcomes of breast conservation therapy
in Iran to determine overall and disease-free survival and
local recurrence rates. At the same time the quality of
available radiotherapy services should be evaluated. Per-
haps this information might help to improve breast can-
cer outcomes.
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